Molecular Sub-Classification of renal epithelial tumors using Meta-Analysis of gene expression microarrays

PLoS ONE

Volumn 6, Issue 7, 2011, Pages

  Sanford, Thomas ^a   Chung, Paul H ^a   Reinish, Ariel ^a   Valera, Vladimir ^a   Srinivasan, Ramaprasad ^a   Linehan, W Marston ^a   Bratslavsky, Gennady ^a,b  

^a NATIONAL CANCER INSTITUTE   (United States)

^b STATE UNIVERSITY OF NEW YORK   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACCURACY; ALGORITHM; ARTICLE; CLEAR CELL CARCINOMA; GENE EXPRESSION; HISTOPATHOLOGY; KIDNEY CARCINOMA; KIDNEY TUMOR; MICROARRAY ANALYSIS; ONCOCYTOMA; PAPILLARY CARCINOMA; PREDICTION; TUMOR CLASSIFICATION; CLASSIFICATION; CLUSTER ANALYSIS; DNA MICROARRAY; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETIC DATABASE; GENETICS; HUMAN; META ANALYSIS; METHODOLOGY; NEOPLASM; REPRODUCIBILITY; STANDARD;

ALGORITHMS; CLUSTER ANALYSIS; DATABASES, GENETIC; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; KIDNEY NEOPLASMS; NEOPLASMS, GLANDULAR AND EPITHELIAL; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; REFERENCE STANDARDS; REPRODUCIBILITY OF RESULTS;

EID: 79960758585     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0021260     Document Type: Article

References (40)

1. Linehan WM, Walther MM, Zbar B, (2003) The genetic basis of cancer of the kidney. J Urol 170: 2163-2172.
2. Amin MB, Tamboli P, Javidan J, Stricker H, de-Peralta Venturina M, et al. (2002) Prognostic impact of histologic subtyping of adult renal epithelial neoplasms: an experience of 405 cases. Am J Surg Pathol 26: 281-291.
3. Delahunt B, Bethwaite PB, Nacey JN, (2007) Outcome prediction for renal cell carcinoma: evaluation of prognostic factors for tumours divided according to histological subtype. Pathology 39: 459-465.
4. Schmidt L, Junker K, Nakaigawa N, Kinjerski T, Weirich G, et al. (1999) Novel mutations of the MET proto-oncogene in papillary renal carcinomas. Oncogene 18: 2343-2350.
5. Schmidt L, Duh FM, Chen F, Kishida T, Glenn G, et al. (1997) Germline and somatic mutations in the tyrosine kinase domain of the MET proto-oncogene in papillary renal carcinomas. Nature Genetics 16: 68-73.
6. Nickerson ML, Warren MB, Toro JR, Matrosova V, Glenn G, et al. (2002) Mutations in a novel gene lead to kidney tumors, lung wall defects, and benign tumors of the hair follicle in patients with the Birt-Hogg-Dube syndrome. Cancer Cell 2: 157-164.
7. Gnarra JR, Tory K, Weng Y, Schmidt L, Wei MH, et al. (1994) Mutations of the VHL tumour suppressor gene in renal carcinoma. Nature Genetics 7: 85-90.
8. Nickerson ML, Jaeger E, Shi Y, Durocher JA, Mahurkar S, et al. (2008) Improved identification of von Hippel-Lindau gene alterations in clear cell renal tumors. Clinical Cancer Research 14: 4726-4734.
9. Motzer RJ, Hutson TE, Tomczak P, Michaelson MD, Bukowski RM, et al. (2007) Sunitinib versus interferon alfa in metastatic renal-cell carcinoma. N Engl J Med 356: 115-124.
10. Eder JP, Vande Woude GF, Boerner SA, LoRusso PM, (2009) Novel therapeutic inhibitors of the c-Met signaling pathway in cancer. Clin Cancer Res 15: 2207-2214.
11. Kummerlin I, ten Kate F, Smedts F, Horn T, Algaba F, et al. (2009) Diagnostic problems in the subtyping of renal tumors encountered by five pathologists. Pathol Res Pract 205: 27-34.
12. Allory Y, Bazille C, Vieillefond A, Molinie V, Cochand-Priollet B, et al. (2008) Profiling and classification tree applied to renal epithelial tumours. Histopathology 52: 158-166.
13. Shi L, Reid LH, Jones WD, Shippy R, Warrington JA, et al. (2006) The MicroArray Quality Control (MAQC) project shows inter- and intraplatform reproducibility of gene expression measurements. Nat Biotechnol 24: 1151-1161.
14. Ramasamy A, Mondry A, Holmes CC, Altman DG, (2008) Key issues in conducting a meta-analysis of gene expression microarray datasets. PLoS Med 5: e184.
15. Simon R, Lam A, Li MC, Ngan M, Menenzes S, et al. (2007) Analysis of Gene Expression Data Using BRB-Array Tools. Cancer Inform 3: 11-17.
16. Wu Z, Irizarry RA, (2004) Preprocessing of oligonucleotide array data. Nat Biotechnol 22: 656-658; author reply 658.
17. Cope L, Zhong X, Garrett E, Parmigiani G, (2004) MergeMaid: R tools for merging and cross-study validation of gene expression data. Stat Appl Genet Mol Biol 3: Article29.
18. Dobbin KK, Zhao Y, Simon RM, (2008) How large a training set is needed to develop a classifier for microarray data? Clin Cancer Res 14: 108-114.
19. Hong F, Breitling R, McEntee CW, Wittner BS, Nemhauser JL, et al. (2006) RankProd: a bioconductor package for detecting differentially expressed genes in meta-analysis. Bioinformatics 22: 2825-2827.
20. Hong F, Breitling R, (2008) A comparison of meta-analysis methods for detecting differentially expressed genes in microarray experiments. Bioinformatics 24: 374-382.
21. Bo T, Jonassen I, (2002) New feature subset selection procedures for classification of expression profiles. Genome Biol 3: RESEARCH0017.
22. Liu N, Khurana K, Sanford T, Aprelikova O, Worrell R, et al. (2009) Impact of ischemia and tissue procurement conditions on gene expression in renal cell carcinoma. J Urol 181: 155-156.
23. Wright G, Tan B, Rosenwald A, Hurt EH, Wiestner A, et al. (2003) A gene expression-based method to diagnose clinically distinct subgroups of diffuse large B cell lymphoma. Proc Natl Acad Sci U S A 100: 9991-9996.
24. Dabney AR, (2005) Classification of microarrays to nearest centroids. Bioinformatics 21: 4148-4154.
25. Jones J, Otu H, Spentzos D, Kolia S, Inan M, et al. (2005) Gene signatures of progression and metastasis in renal cell cancer. Clin Cancer Res 11: 5730-5739.
26. Kort EJ, Farber L, Tretiakova M, Petillo D, Furge KA, et al. (2008) The E2F3-Oncomir-1 axis is activated in Wilms' tumor. Cancer Res 68: 4034-4038.
27. Yusenko MV, Kuiper RP, Boethe T, Ljungberg B, van Kessel AG, et al. (2009) High-resolution DNA copy number and gene expression analyses distinguish chromophobe renal cell carcinomas and renal oncocytomas. BMC Cancer 9: 152.
28. Furge KA, Lucas KA, Takahashi M, Sugimura J, Kort EJ, et al. (2004) Robust classification of renal cell carcinoma based on gene expression data and predicted cytogenetic profiles. Cancer Res 64: 4117-4121.
29. Gumz ML, Zou H, Kreinest PA, Childs AC, Belmonte LS, et al. (2007) Secreted frizzled-related protein 1 loss contributes to tumor phenotype of clear cell renal cell carcinoma. Clin Cancer Res 13: 4740-4749.
30. Koeman JM, Russell RC, Tan MH, Petillo D, Westphal M, et al. (2008) Somatic pairing of chromosome 19 in renal oncocytoma is associated with deregulated EGLN2-mediated [corrected] oxygen-sensing response. PLoS Genet 4: e1000176.
31. Rohan S, Tu JJ, Kao J, Mukherjee P, Campagne F, et al. (2006) Gene expression profiling separates chromophobe renal cell carcinoma from oncocytoma and identifies vesicular transport and cell junction proteins as differentially expressed genes. Clin Cancer Res 12: 6937-6945.
32. Yang XJ, Sugimura J, Schafernak KT, Tretiakova MS, Han M, et al. (2006) Classification of renal neoplasms based on molecular signatures. J Urol 175: 2302-2306.
33. Pusztai L, Hess KR, (2004) Clinical trial design for microarray predictive marker discovery and assessment. Ann Oncol 15: 1731-1737.
34. Truong LD, Shen SS, (2011) Immunohistochemical diagnosis of renal neoplasms. Archives of Pathology and Laboratory Medicine 135: 92-109.
35. Simon R, (2006) Development and evaluation of therapeutically relevant predictive classifiers using gene expression profiling. Journal of the National Cancer Institute 98: 1169-1171.
36. Cardoso F, Van't Veer L, Rutgers E, Loi S, Mook S, et al. (2008) Clinical application of the 70-gene profile: the MINDACT trial. Journal of Clinical Oncology 26: 729-735.
37. Poleev A, Fickenscher H, Mundlos S, Winterpacht A, Zabel B, et al. (1992) PAX8, a human paired box gene: isolation and expression in developing thyroid, kidney and Wilms' tumors. Development 116: 611-623.
38. Miyoshi N, Ishii H, Mimori K, Sekimoto M, Doki Y, et al. (2010) SCRN1 is a novel marker for prognosis in colorectal cancer. Journal of Surgical Oncology 101: 156-159.
39. Tan MH, Wong CF, Tan HL, Yang XJ, Ditlev J, et al. (2010) Genomic expression and single-nucleotide polymorphism profiling discriminates chromophobe renal cell carcinoma and oncocytoma. BMC Cancer 10: 196.
40. Furge KA, Chen J, Koeman J, Swiatek P, Dykema K, et al. (2007) Detection of DNA copy number changes and oncogenic signaling abnormalities from gene expression data reveals MYC activation in high-grade papillary renal cell carcinoma. Cancer Research 67: 3171-3176.